According to Allogene Therapeutics 's latest financial reports the company's current revenue (TTM ) is -NZ$0.04 Million. In 2023 the company made a revenue of NZ$0.04 Million a decrease over the revenue in the year 2022 that were of NZ$0.38 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | -NZ$0.04 Million | -168.95% |
2023 | NZ$0.04 M | -87.61% |
2022 | NZ$0.38 M | -99.32% |
2021 | NZ$56.34 M | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A |